Thymic carcinoma outcomes and prognosis: Results of an international analysis Usman Ahmad, MD, Xiaopan Yao, PhD, Frank Detterbeck, MD, James Huang, MD,

Slides:

Advertisements

Similar presentations

Improved survival with pulmonary metastasectomy: An analysis of 1720 patients with pulmonary metastatic melanoma Rebecca P. Petersen, MD, MSc, Steven.

Advertisements

Prognostic impacts of EGFR mutation status and subtype in patients with surgically resected lung adenocarcinoma Kazuya Takamochi, MD, Shiaki Oh, MD,

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Manuel J. Antunes, MD, PhD, DSc

Stephen R. Broderick, MD, MPHS

A wolf in sheep's clothing

Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis? Atsushi Watanabe, MD, PhD, Tetsuya Higami, MD, PhD, Syunsuke Ohori,

The eighth edition TNM stage classification for lung cancer: What does it mean on main street? Frank C. Detterbeck, MD The Journal of Thoracic and Cardiovascular.

Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection Morihito Okada,

“Lead from the front”: Participative leadership

Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system Shamus R.

The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposals for the T component for the Forthcoming (8th) Edition of the TNM Classification of.

Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: A population-based Scandinavian Sarcoma Group study of 106 patients Björn.

Pleomorphic carcinoma of the lung: A surgical outcome

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer Hong.

The Impact of Thymoma Histotype on Prognosis in a Worldwide Database

Multimodality therapy for locally advanced thymomas: A propensity score–matched cohort study from the European Society of Thoracic Surgeons Database

William M. DeCampli, MD, PhD

Multilevel data analysis: What? Why? How?

Go on-pump or off-pump in diabetic patients?

Standard Outcome Measures for Thymic Malignancies

Resection and heated pleural chemoperfusion in patients with thymic epithelial malignant disease and pleural spread: A single-institution experience

Clinical Characteristics and Outcomes for Patients With Thymic Carcinoma: Evaluation of Masaoka Staging Anya M. Litvak, MD, Kaitlin Woo, MS, Sara Hayes,

The lord of the rings Antonio Miceli, MD, PhD

Esophagectomy versus endoscopic resection for patients with early-stage adenocarcinoma: Mercedes versus Tesla Toni Lerut, MD The Journal of Thoracic.

Spontaneous pneumomediastinum: A rare complication of anorexia nervosa

A systematic review and meta-analysis of stereotactic body radiation therapy versus surgery for patients with non–small cell lung cancer Christopher.

Expanding left ventricular assist device use to patients with disabilities: The role of assistive technology Juan A. Crestanello, MD The Journal of.

Kyle W. Riggs, MD, David L.S. Morales, MD

Predictors of recurrence and disease-free survival in patients with completely resected esophageal carcinoma Paul C. Lee, MD, Farooq M. Mirza, MD, Jeffrey.

Postinduction positron emission tomography assessment of N2 nodes is not associated with ypN2 disease or overall survival in stage IIIA non–small cell.

Development of the International Thymic Malignancy Interest Group International Database: An Unprecedented Resource for the Study of a Rare Group of Tumors

Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.

Thymic Carcinoma Management Patterns among International Thymic Malignancy Interest Group (ITMIG) Physicians with Consensus from the Thymic Carcinoma.

It's not “just a shunt” but sometimes it should be…

Do we need a bibliometrician to know which way the wind is blowing?

A first start for lung transplantation?

Stephen R. Broderick, MD, MPHS

Third-time lung transplantation in a patient with cystic fibrosis

Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass Benjamin Medalion, MD, Michael G. Katz, MD,

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Niv Ad, MD, Lawrence M. Wei, MD

Frozen elephant trunk technique: Ready to get back to the future?

Attachment disorder in thoracoabdominal surgery

The Ross procedure: Time to reevaluate the guidelines

Manuel J. Antunes, MD, PhD, DSc

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Prognosis and “granularity”: Building on staging foundations?

International Thymic Malignancies Interest Group: A Way Forward

Functional tricuspid pathology: To treat or not to treat

Improved survival with pulmonary metastasectomy: An analysis of 1720 patients with pulmonary metastatic melanoma Rebecca P. Petersen, MD, MSc, Steven.

Sebastien Gilbert, MD, Andre B. Martel, BSc, Andrew J

Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural.

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Multidisciplinary treatment of advanced thymic neuroendocrine carcinoma (carcinoid): Report of a successful case and review of the literature Pier Luigi.

The future of cardiac surgery training: A survival guide

Ventricular assistant in restrictive cardiomyopathy: Making the right connection Robert D.B. Jaquiss, MD The Journal of Thoracic and Cardiovascular Surgery

Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement Todd M. Dewey,

Hemoptysis caused by an endobronchial lipoma

Therapeutic R2 resection for pleural mesothelioma

“The more things change…”: The challenges ahead

Apples remain apples NO matter what

Energized lung resections

The evolution of cardiothoracic critical care

Did you like Terminator 3 better than Terminator 2

How do we follow up our patients

Paraneoplastic Syndromes and Thymic Malignancies: An Examination of the International Thymic Malignancy Interest Group Retrospective Database Sukhmani.

Presentation transcript:

Thymic carcinoma outcomes and prognosis: Results of an international analysis Usman Ahmad, MD, Xiaopan Yao, PhD, Frank Detterbeck, MD, James Huang, MD, Alberto Antonicelli, MD, Pier Luigi Filosso, MD, Enrico Ruffini, MD, William Travis, MD, David R. Jones, MD, Yilei Zhan, MD, Marco Lucchi, MD, Andreas Rimner, MD The Journal of Thoracic and Cardiovascular Surgery Volume 149, Issue 1, Pages 95-101.e2 (January 2015) DOI: 10.1016/j.jtcvs.2014.09.124 Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Association of pathologic Masaoka stage and resection status with overall survival and cumulative incidence of recurrence. A, Overall survival by pathologic stage in all patients with thymic carcinoma regardless of resection status. B, Cumulative incidence of recurrence by pathologic stage in all patients with thymic carcinoma regardless of resection status. The Journal of Thoracic and Cardiovascular Surgery 2015 149, 95-101.e2DOI: (10.1016/j.jtcvs.2014.09.124) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Association of histologic subtype with overall survival and cumulative incidence of recurrence. A, Overall survival by histologic subtype in all patients. B, Cumulative incidence of recurrence by histologic subtype in all patients. The Journal of Thoracic and Cardiovascular Surgery 2015 149, 95-101.e2DOI: (10.1016/j.jtcvs.2014.09.124) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Figure E1 Association of histologic subtype with overall survival and cumulative incidence of recurrence in R0 patients. A, Overall survival by histologic subtype in R0 resected patients only. B, Cumulative incidence of recurrence by histologic subtype in R0 resected patients only. The Journal of Thoracic and Cardiovascular Surgery 2015 149, 95-101.e2DOI: (10.1016/j.jtcvs.2014.09.124) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Figure E2 Association of pathologic resection status with overall survival. A, Overall survival by resection status in all pathologic stages. B, Overall survival by pathologic stage in R0 resected patients only. C, Recurrence-free survival by resection status in all pathologic stages. The Journal of Thoracic and Cardiovascular Surgery 2015 149, 95-101.e2DOI: (10.1016/j.jtcvs.2014.09.124) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions